Kenya will be integrating HIV and TB management into routine healthcare services, moving away from treating them as standalone programmes, as part of the stop-gap measures to aid Kenyans who were dependent on USAID to receive treatment.
The US government, through the President's Emergency Plan for AIDS Relief (PEPFAR) and the United States Agency for International Development (USAID), has been supporting various efforts, including medical research, the treatment of Tuberculosis (TB), HIV, and AIDS, as well as malaria.
Over the last 40 years, the US government has been supporting treatment that has reached 3.7 million Kenyans with HIV medications, according to the Ministry of Health.
While addressing the press at Afya House on Wednesday, Health Cabinet Secretary Deborah Barasa dismissed calls for alarm over the withdrawal of US funding that has been supporting various treatment and research activities in the country.
